ST Nordit: Jinde Factory's Active Pharmaceutical Ingredient Production Line Passes GMP Compliance Inspection.

date
03/02/2026
ST Notai announced that its wholly-owned subsidiary Hangzhou Ausino Biotechnology Co., Ltd. recently received the "Drug GMP Compliance Inspection Notification" issued by the Zhejiang Provincial Drug Administration, and the Ausino Adefovir Dipivoxil API officially passed the GMP compliance inspection. The inspection scope and related workshops and production lines for the API are: Workshop 1, Workshop 6, Workshop 9, and API production line B. The conclusion is that the production and quality management of Workshop 1, Workshop 6, Workshop 9, and API production line B of the company's API comply with the requirements of the "Drug Production Quality Management Specifications."